Immune dysfunction and neuroinflammation in autism spectrum disorder.

Geir Bjorklund, Khaled Saad, Salvatore Chirumbolo, Janet K Kern, David A Geier, Mark R Geier, Mauricio A Urbina

Journal: Acta neurobiologiae experimentalis 2017;76(4):257-268

PMID: 28094817

Abstract

Autism spectrum disorder (ASD) is a complex heterogeneous neurodevelopmental disorder with a complex pathogenesis. Many studies over the last four decades have recognized altered immune responses among individuals diagnosed with ASD. The purpose of this critical and comprehensive review is to examine the hypothesis that immune dysfunction is present more frequently, and it is related to ASD in humans. It was found that that often individuals diagnosed with ASD have alterations in immune cells such as T cells, B cells, monocytes, natural killer cells, and dendritic cells. Also, many individuals diagnosed with ASD have alterations in immunoglobulins and increased autoantibodies. Finally, an important portion of individuals diagnosed with ASD has elevated peripheral cytokines and chemokines and associated neuroinflammation. In conclusion, immune dysregulation and inflammation are important components of ASD diagnosis and are key components of the diagnosis and treatment of ASD.

Address: Council for Nutritional and Environmental Medicine, Mo i Rana, Norway, [email protected].; Department of Pediatrics, Faculty of Medicine, Assiut University, Assiut, Egypt.; Department of Neurological and Movement Science, University of Verona, Verona, Italy.; Institute of Chronic Illnesses, Inc., Silver Spring, MD, USA.; Departamento de Zoología, Facultad de Ciencias Naturales y Oceanográficas, Universidad de Concepción, Concepción, Chile.
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.